Abstract:Introduction Impaired awareness of hypoglycemia (IAH) refers to a diminished capacity to detect hypoglycemia. IAH can result in severe and even life-threatening outcomes for individuals with diabetes, especially those in advanced stages of the disease. This study aimed to assess the prevalence of IAH in people with diabetes on hemodialysis. Research design and methods We conducted a single-center audit to assess the prevalence of IAH using the Clarke questionnaire. Simultaneously, we measured fear of hypoglycemia with an adapted version of the Hypoglycemia Survey and recorded the incidence of severe hypoglycemia. Data were presented as mean±SD or counts/percentages. Logistic regression was then employed to analyze the association between IAH and various sociodemographic and clinical factors. Results We included 56 participants with diabetes on hemodialysis, with a mean age of 67.2 years (±12.9), of whom 51.8% were male. The ethnic distribution was 23.2% white, 23.2% black, 19.6% Asian, and 33.9% unspecified. The mean HbA1c was 52 mmol/mol (±18.6). The majority (91.1%) had a diagnosis of type 2 diabetes, and 55.4% of those were treated with insulin. The use of diabetes technology was low, with 2.8% of the participants using a continuous glucose monitor. IAH prevalence was 23.2%, and among the 57 participants, 23.6% had a history of severe hypoglycemia, and 60.6% reported fear of hypoglycemia. There were no significant differences in sociodemographic and clinical characteristics between those with IAH and normal hypoglycemia awareness. Conclusions We observed that 23.2% of individuals with diabetes undergoing hemodialysis had IAH. IAH was more prevalent in people who reported a fear of hypoglycemia and had a history of severe hypoglycemia episode. The study highlights the unmet needs and disparities in access to diabetes technology within this population.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the prevalence of Impaired Awareness of Hypoglycemia (IAH) in diabetic patients during hemodialysis. Specifically, the study aims to: 1. **Evaluate the prevalence**: Through a single - center audit, use the Clarke questionnaire to evaluate the prevalence of IAH in diabetic patients during hemodialysis. 2. **Correlation analysis**: At the same time, measure the patients' fear of hypoglycemia and record the incidence of severe hypoglycemia. Through logistic regression analysis, explore the relationship between IAH and various sociodemographic and clinical factors. ### Research background Hypoglycemia is a common complication in the treatment of diabetes, especially in patients using sulfonylureas (SU) or insulin. For diabetic patients receiving renal replacement therapy (KRT), due to multiple factors (such as reduced gluconeogenesis, reduced clearance of insulin and hypoglycemic drugs, reduced insulin degradation and the influence of uremic toxins), they are more likely to develop hypoglycemia. In addition, these patients may suffer from malnutrition due to loss of appetite, further exacerbating the occurrence of hypoglycemia. ### Research objectives 1. **Evaluate the prevalence of IAH**: Determine the prevalence of IAH in diabetic patients during hemodialysis. 2. **Explore related factors**: Analyze the relationship between IAH and sociodemographic and clinical characteristics, especially explore whether IAH is related to hypoglycemia fear and a history of severe hypoglycemia. ### Research methods - **Research design**: Single - center prospective audit. - **Participants**: Diabetic patients aged 18 and above, who are receiving hemodialysis and are treated with SU or insulin. - **Data collection**: Use the Clarke score to evaluate hypoglycemia awareness, use the adapted hypoglycemia fear survey questionnaire to evaluate patients' fear of hypoglycemia, and record the occurrence of severe hypoglycemia in the past 12 months. - **Statistical analysis**: Descriptive statistics are used to summarize the basic characteristics of participants, and logistic regression analysis is used to explore the relationship between IAH and various factors. ### Main findings - **IAH prevalence**: 23.2% of diabetic patients have IAH during hemodialysis. - **Severe hypoglycemia**: 23.6% of participants have experienced at least one severe hypoglycemia event in the past 12 months. - **Hypoglycemia fear**: 60.6% of participants report having hypoglycemia fear. - **Related factors**: IAH is more common in patients who report hypoglycemia fear and have a history of severe hypoglycemia, but no significant association was found between IAH and age, gender, mean BMI, mean systolic blood pressure or mean HbA1c level. ### Conclusion This study is the first to evaluate the prevalence of IAH in diabetic patients during hemodialysis and found that nearly a quarter of this population has IAH, which increases their risk of developing severe hypoglycemia. The study emphasizes the importance of regular evaluation of hypoglycemia awareness status to reduce the risks of hypoglycemia, severe hypoglycemia and IAH. In addition, the study also points out the lack of access to diabetes technologies in this population, and more research is needed to determine whether these technologies can effectively reduce the incidence of hypoglycemia.

Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis

Prevalence and risk factors for impaired awareness of hypoglycaemia: A registry‐based study of 10,202 adults with type 1 diabetes in Norway

Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches

Impaired Awareness of Hypoglycemia Disrupts Blood Flow to Brain Regions Involved in Arousal and Decision Making in Type 1 Diabetes

Standards of diabetes care and burden of hypoglycaemia in people with diabetes on peritoneal dialysis: Results from a real-world clinical audit

Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study

Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey

Effect of Hypoglycemia on Heart Rate Variability in People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia

Beliefs Around Hypoglycemia and Their Impacts on Hypoglycemia Outcomes in Individuals with Type 1 Diabetes and High Risks for Hypoglycemia Despite Using Advanced Diabetes Technologies

Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia

Diabetic autonomic neuropathy does not impede improvement in hypoglycaemia awareness in adults: Sub‐study results from the HypoCOMPaSS trial

Awareness Level of Hypoglycemia Among Diabetes Mellitus Type 2 Patients in Al Qassim Region

Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey

Detection of Hypoglycemia by Children With Type 1 Diabetes 6 to 11 Years of Age and Their Parents: A Field Study

Metabolomic associations of impaired awareness of hypoglycaemia in type 1 diabetes

Hypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications

Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore

Awareness of Diabetes Complication in Subjects with Type 2 Diabetes

Hypoglycemia symptoms are reduced in hospitalized patients with diabetes